US CMS confirms US$127.14 outpatient payment rate for AROA ECM™ sheet products in 2027
The US Centers for Medicare & Medicaid Services (CMS) published its final reimbursement rules for calendar year 2027 on 4 November, and the existing payment rate of US$127.14 per square centimetre of wound area treated will continue in 2027. Aroa Biosurgery Limited (ASX: ARX) said the outcome provides reimbursement stability and certainty for AROA ECM™ sheet products in outpatient settings.
The company said the rate applies to Symphony™ in hospital outpatient departments, ambulatory surgical centres and physician offices. This is consistent with the proposed framework outlined in AROA’s 14 July 2026 announcement.
Brian Ward, Founder and CEO
“We welcome the greater payment certainty these rules provide for healthcare providers and hospitals following significant change in outpatient reimbursement. Symphony is well positioned in this environment, supported by compelling clinical evidence and responsible pricing.”
When big ASX news breaks, our subscribers know first
New national payment rate for non-sheet products in physician’s offices
From 1 January 2027, a national product payment rate of US$127.14 per square centimetre will apply to non-sheet products in physician’s offices. Payment is based on the wound area treated in square centimetres.
The company said this creates a new opportunity for morcellised versions of AROA ECM™.
AROA also set out the following context:
- Myriad in the hospital inpatient setting remains its primary focus, where reimbursement is well established and unaffected by these outpatient changes.
- Recent changes in outpatient reimbursement support the opportunity for Symphony.
- AROA believes Symphony’s responsible pricing, supported by its recently published randomised controlled trial, positions it well for adoption in the outpatient setting.
The published randomised controlled trial reported complete wound closure in 55% of diabetic foot ulcer patients at 12 weeks versus 35% for standard care alone, giving Symphony Level I evidence in the outpatient market.
Want the Next Healthcare Breakout in Your Inbox?
Get FREE breaking ASX healthcare news delivered within minutes of release, complete with in-depth analysis. Join 20,000+ investors already receiving real-time alerts from Big News Blast. Click the “Free Alerts” button to stay ahead of the market the moment the next big announcement lands.